Gelteq Ltd Logo

Gelteq Ltd

Ingestible gel platform for enhanced oral delivery of drugs & nutrients for human & animal health.

GELS | NDAQ

Overview

Corporate Details

ISIN(s):
AU0000218109
LEI:
Country:
United States of America
Address:
LEVEL 4, 3205 SOUTH MELBOURNE VIC
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Gelteq Ltd is a biotechnology company specializing in a proprietary, ingestible gel platform for the oral delivery of drugs and nutrients. Its patented technology converts existing orally delivered compounds into a customizable gel format designed to improve absorption, reduce choking risks, and address issues like dysphagia. A key feature of the platform is its stable matrix that can simultaneously integrate both water-soluble and lipid-soluble components. The company operates on a partnership model, providing white-label and tailored solutions for the pharmaceutical, nutraceutical, sports nutrition, and pet care industries, serving both human and animal markets. The technology was developed in collaboration with Monash University.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Gelteq Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Gelteq Ltd

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Gelteq Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Coherus Oncology, Inc. Logo
Commercial-stage biopharma developing immuno-oncology therapies for hard-to-treat cancers.
United States of America CHRS
COLLEGIUM PHARMACEUTICAL, INC Logo
Develops and commercializes abuse-deterrent medications for responsible chronic pain management.
United States of America COLL
CollPlant Biotechnologies Ltd Logo
Develops rhCollagen for 3D bioprinting of tissues for regenerative & aesthetic medicine.
United States of America CLGN
Compass Therapeutics, Inc. Logo
A clinical-stage oncology firm developing antibody therapies that engage the immune system.
United States of America CMPX
Compugen Ltd. Logo
Uses AI to discover and develop novel antibody immunotherapies for hard-to-treat cancers.
Israel CGEN
COMPUGEN LTD Logo
AI-driven discovery of novel cancer immunotherapies for treatment-resistant patients.
United States of America CGEN
Connect Biopharma Holdings Ltd Logo
Develops immune modulators for T cell-driven inflammatory diseases like asthma and COPD.
United States of America CNTB
Context Therapeutics Inc. Logo
Clinical-stage biopharma developing T cell engaging bispecific antibodies for solid tumors.
United States of America CNTX
Contineum Therapeutics, Inc. Logo
Develops oral small molecule therapies for neurological, inflammatory, and fibrotic diseases.
United States of America CTNM
CORCEPT THERAPEUTICS INC Logo
Develops and commercializes cortisol-modulating drugs for severe disorders like Cushing's syndrome.
United States of America CORT

Talk to a Data Expert

Have a question? We'll get back to you promptly.